Purchase Order 75N95025P00351
Award Date
9/1/25
Potential Completion Date
8/31/28
Potential Value
$34K
Federal Agency
National Institute on Drug Abuse
Awardee
Optibrium LIMITED
Ultimate Awardee
Not listed
NAICS Category
513210 - Software Publishers
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services, awarded a firm-fixed-price purchase order contract to Chemaxon LLC for annual license renewals of the JChem Oracle Cartridge and Marvin JS software. The $56,418.00 contract will provide the AIMS (ATDP Information Management System) application with access to these critical cheminformatics tools from July 1, 2024 through June 30, 2025, with potential...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $452,500.00 firm fixed-price purchase order contract to Chemroutes Corporation, a foreign-owned for-profit organization, for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program. The contract has an ultimate completion date of April 30, 2016 and was awarded on December 23, 2015. This contract was not set aside for any particular business type.</p>
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $183,731.46 firm-fixed-price purchase order contract to Oxford Stemtech LTD for scientific support services related to the generation and multiomics profiling of induced pluripotent stem cell-derived neuronal models. The contract does not have a set-aside designation, and the ultimate completion date is September 10, 2025. This contract award is not associated with a larger acquisition vehicle.</p>
The National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), awarded a $23,000.00 firm-fixed-price purchase order to Schrodinger LLC, a division of Schrodinger, Inc. The contract is for Schrodinger software licenses, including the Small Molecule Drug Discovery Suite, Schrodinger Suite, LiveDesign, Comptox, and Materials Science Suite, to support computational chemistry and molecular biophysics research efforts. The contract does not...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price purchase order contract to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for a Drug Research Advisor subscription, Off-X (Translational Safety/Toxicology) and Cortellis Drug Discovery Intelligence software with Biomarkers Module. The period of performance is April 1, 2021 to March 31, 2022, with two one-year option periods. The potential...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $12,000.00 firm-fixed-price purchase order contract to Vivpro Corp, a self-certified small disadvantaged business, for subscription licenses. The contract has an ultimate completion date of June 24, 2025 and was awarded on June 13, 2024. This contract does not have a set-aside designation.</p>
<p>This is a $460,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Charles River Discovery Research Services UK LIMITED, a foreign-owned for-profit organization. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a performance period ending on January 31, 2016. The contract does not have a set-aside designation.</p>
<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $87,672.00 Firm Fixed Price Purchase Order contract to Glixx Laboratories, Inc., a self-certified small disadvantaged business. The contract is part of the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, and has an ultimate completion date of November 30, 2015. The contract does not have a set-aside designation.</p>